Nikos Pagratis

1.4k total citations
30 papers, 668 citations indexed

About

Nikos Pagratis is a scholar working on Molecular Biology, Infectious Diseases and Hepatology. According to data from OpenAlex, Nikos Pagratis has authored 30 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Infectious Diseases and 6 papers in Hepatology. Recurrent topics in Nikos Pagratis's work include HIV/AIDS drug development and treatment (9 papers), Hepatitis C virus research (6 papers) and Bacteriophages and microbial interactions (5 papers). Nikos Pagratis is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), Hepatitis C virus research (6 papers) and Bacteriophages and microbial interactions (5 papers). Nikos Pagratis collaborates with scholars based in United States, Australia and Germany. Nikos Pagratis's co-authors include Ying-Fon Chang, Carol Bell, Tim Fitzwater, Susan Jennings, Derek Jellinek, Helen R. Revel, Tian Yang, William E. Delaney, Betty Peng and Romas Geleziunas and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Biotechnology.

In The Last Decade

Nikos Pagratis

30 papers receiving 641 citations

Peers

Nikos Pagratis

HEPAT

EPIDE

CCM

Laurent Bellon United States

Philippe Neuner Italy

Claire Gondeau France

Kerstin Jahn‐Hofmann Germany

Patricia Feldman United States

Joel D. Federspiel United States

Peng He China

Weimei Xing United States

N. Robert France

Manish Kandpal India

Laurent Bellon United States

Nikos Pagratis

500 ×1.2

92 ×0.9

HEPAT

70 ×0.7

EPIDE

98 ×1.1

41 ×0.6

CCM

Citations per year, relative to Nikos Pagratis Nikos Pagratis (= 1×) peers Laurent Bellon

Countries citing papers authored by Nikos Pagratis

Since Specialization

Citations

This map shows the geographic impact of Nikos Pagratis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikos Pagratis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikos Pagratis more than expected).

Fields of papers citing papers by Nikos Pagratis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikos Pagratis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikos Pagratis. The network helps show where Nikos Pagratis may publish in the future.

Co-authorship network of co-authors of Nikos Pagratis

This figure shows the co-authorship network connecting the top 25 collaborators of Nikos Pagratis. A scholar is included among the top collaborators of Nikos Pagratis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikos Pagratis. Nikos Pagratis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lebek, Simon, Maria J. Baier, Julian Mustroph, et al.. (2018). The novel CaMKII inhibitor GS-680 reduces diastolic SR Ca leak and prevents CaMKII-dependent pro-arrhythmic activity. Journal of Molecular and Cellular Cardiology. 118. 159–168. 42 indexed citations

Yu, Helen, Hoa Truong, Scott A. Mitchell, et al.. (2018). Homogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target Engagement. SLAS DISCOVERY. 23(9). 919–929. 13 indexed citations

Koltun, Dmitry O., Rao Kalla, Thao Perry, et al.. (2017). Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII). Bioorganic & Medicinal Chemistry Letters. 28(3). 541–546. 5 indexed citations

Cheng, Guofeng, Tian Yang, Brian Doehle, et al.. (2016). In Vitro Antiviral Activity and Resistance Profile Characterization of the Hepatitis C Virus NS5A Inhibitor Ledipasvir. Antimicrobial Agents and Chemotherapy. 60(3). 1847–1853. 50 indexed citations

Liang, Faquan, Peidong Fan, Suya Yang, et al.. (2016). Inhibitions of late I Na and CaMKII act synergistically to prevent ATX-II-induced atrial fibrillation in isolated rat right atria. Journal of Molecular and Cellular Cardiology. 94. 122–130. 16 indexed citations

Lad, Latesh, et al.. (2014). High-Throughput Kinetic Screening of Hybridomas to Identify High-Affinity Antibodies Using Bio-Layer Interferometry. SLAS DISCOVERY. 20(4). 498–507. 31 indexed citations

Niedziela‐Majka, Anita, Latesh Lad, Jeffrey W. Chisholm, et al.. (2012). Lipid-Sensing High-Throughput ApoA-I Assays. SLAS DISCOVERY. 17(8). 1050–1061. 3 indexed citations

Yu, Min, Simin Xu, Bo Han, et al.. (2012). 825 DEVELOPMENT AND MOLECULAR CHARACTERIZATION OF A ROBUST GENOTYPE 4 HEPATITIS C VIRUS SUBGENOMIC REPLICON. Journal of Hepatology. 56. S322–S322. 1 indexed citations

Huynh, Q K, Sarah Wise, Keith A. Koch, et al.. (2011). Screening and Identification of a Novel Class of TGF-β Type 1 Receptor Kinase Inhibitor. SLAS DISCOVERY. 16(7). 724–733. 6 indexed citations

10.

Gamber, Gabriel G., Erik L. Meredith, Michael Capparelli, et al.. (2011). 3,5-Diarylazoles as novel and selective inhibitors of protein kinase D. Bioorganic & Medicinal Chemistry Letters. 21(5). 1447–1451. 27 indexed citations

11.

Berry, Katherine E., Betty Peng, David Koditek, et al.. (2011). Optimized High-Throughput Screen for Hepatitis C Virus Translation Inhibitors. SLAS DISCOVERY. 16(2). 211–220. 8 indexed citations

12.

Huynh, Q K & Nikos Pagratis. (2010). Kinetic mechanisms of Ca++/calmodulin dependent protein kinases. Archives of Biochemistry and Biophysics. 506(2). 130–136. 4 indexed citations

13.

Monovich, Lauren G., Keith A. Koch, Daniel Wall, et al.. (2009). Suppression of HDAC nuclear export and cardiomyocyte hypertrophy by novel irreversible inhibitors of CRM1. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1789(5). 422–431. 26 indexed citations

14.

Tsiang, Manuel, G.S. Jones, Magdeleine Hung, et al.. (2009). Affinities between the Binding Partners of the HIV-1 Integrase Dimer-Lens Epithelium-derived Growth Factor (IN Dimer-LEDGF) Complex. Journal of Biological Chemistry. 284(48). 33580–33599. 40 indexed citations

15.

Pagratis, Nikos, Carol Bell, Ying-Fon Chang, et al.. (1997). Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factor. Nature Biotechnology. 15(1). 68–73. 162 indexed citations

16.

Pagratis, Nikos. (1996). Rapid preparation of single stranded DNA from PCR products by streptavidin induced electrophoretic mobility shift. Nucleic Acids Research. 24(18). 3645–3646. 34 indexed citations

17.

Pagratis, Nikos & Helen R. Revel. (1993). Broad host range, regulated expression system utilizing bacteriophage T7 RNA polymerase and promoter. Biotechnology and Bioengineering. 41(9). 837–845. 3 indexed citations

18.

Pagratis, Nikos & Helen R. Revel. (1990). Detection of bacteriophage φ6 minus-strand rna and novel rnrna isoconformers synthesized in vivo and in vitro, by strand-separating agarose gels. Virology. 177(1). 273–280. 32 indexed citations

19.

Pagratis, Nikos, et al.. (1990). Vital capillaroscopy on microcirculation: pharmacodynamic activity of Daflon 500 mg in venous insufficiency.. PubMed. 8(4 Suppl). 51–2. 2 indexed citations

20.

Pagratis, Nikos, et al.. (1981). Experience with Buflomedil in Peripheral Arterial Occlusive Disease. Angiology. 32(10). 679–685. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact